BTA 0.00% 57.0¢ biota holdings limited

who update tamiflu resistance to pandemic flu, page-2

  1. 8,256 Posts.
    Well done

    That update is extremely interesting.

    It will be really interesting if/when WHO finally comes out and recommends Relenza over Tamiflu.

    They have resisted till now for various reasons...

    ...but once Lani is released, it will be extremely difficult for WHO to continue to officially favour Tamiflu.

    Now if GSK are able to secure the ROW rights to Lani, they will have a fantastic bargaining point for governments - increase your Relenza:Tamiflu stockpile ratio now and we will come up with an attractive Lani/Relenza replacement option once Lani is released.
 
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.